Bio-pharmaceuticals

Welcoming new member Sarah Dolman

Umbrex is pleased to welcome Sarah Dolman with Healthtech Catalyst. Sarah has 15 years of broad healthcare experience, spanning bio-pharmaceuticals, health-tech, med-tech and insurers. She has spent the last five years advising teams as they define product strategy, identify strategic investors and build deep partnerships. Sarah has experience in top-tier consulting (BCG), health-tech (Verily, f.k.a Google [X] Life Sciences) and drug-development (Merck). Sarah is most excited when projects sit at the interface of science, tech/AI, and care-delivery.